Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Geron Corp (NASDAQ:GERN)

1.98
Delayed Data
As of Nov 22
 0.00 / 0.00%
Today’s Change
1.74
Today|||52-Week Range
3.15
-4.35%
Year-to-Date
No recent news for Geron Corp.

Today’s Trading

Previous close1.98
Today’s open1.96
Day’s range1.93 - 2.00
Volume667,344
Average volume (3 months)1,185,331
Market cap$315.3M
Dividend yield--
Data as of 4:00pm ET, 11/22/2017

Growth & Valuation

Earnings growth (last year)-63,433.33%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-83.06%
P/E ratioNM
Price/Sales53.43
Price/Book2.58

Competitors

 Today’s
change
Today’s
% change
BTXBioTime Inc0.000.00%
EDGEEdge Therapeutics In...0.000.00%
AGENAgenus Inc0.000.00%
BLCMBellicum Pharmaceuti...0.000.00%
Data as of 8:00pm ET, 11/22/2017

Financials

Next reporting dateMarch 7, 2018
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$6.2M
Annual profit (last year)-$29.5M
Net profit margin-479.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John A. Scarlett
Chief Financial Officer, Treasurer &
Executive VP
Olivia K. Bloom
Corporate headquarters
Menlo Park, California

Forecasts